Safety: Clinical Trials

15 trials for Safety, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 unknown, 6 completed, 1 not yet recruiting. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Unknown 8, Completed 6, Not yet recruiting 1

Follow Safety: new trials by email Literature Review of Safety trials Research Report on Safety

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Exploration and Evaluation of Dexmedetomidine Hydrochloride Nasal Spray for Pre-anesthesia Sedation in Low-Monitoring Settings
Dexmedetomidine hydrochloride nasal spray, Placebo - Dexmedetomidine, Sedation
Phase 4Not yet recruitingSichuan Provincial People's Hospital5642026-01-102025-12-23
Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study
mRNA COVID-19 vaccine, IIV4 (quadrivalent inactivated influenza vaccine) - Birth Outcomes, Safety
Phase 4CompletedDuke University982024-09-122026-10-07
Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines
bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza vaccine - Immune Response, Safety
Phase 4CompletedCatholic Kwandong University1542022-10-122024-03-26
Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy
Remimazolam, Propofol group - Anesthetics, Recovery
Phase 4UnknownFirst Affiliated Hospital Xi'an Jiaotong University3002022-07-102022-07-01
Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease
Memantine Oral Tablet, GV-971 capsule - Treatment, Efficacy
Phase 4UnknownFirst Affiliated Hospital Xi'an Jiaotong University1502022-07-012022-07-07
Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23
Vaccine - Safety, Immunogenicity, Vaccine
Phase 4UnknownCenters for Disease Control and Prevention, China30002021-10-082022-03-28
Nalbuphine Versus Morphine for Perioperative Tumor Ablation
Nalbuphine, Morphine - Nalbuphine Allergy, Ablation
Phase 4UnknownZhongda Hospital3162021-09-052022-12-29
Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B
Tenofovir Alafenamide fumarate 25mg Oral Tablet - Chronic Hepatitis B, Mother-to-Child Transmission
Phase 4UnknownThe First Affiliated Hospital of Zhengzhou University2402021-04-262021-04-23
Safety and Efficacy of Sodium Bicarbonate Ringer Injection
sodium bicarbonate Ringer injection, Lactated Ringer's solution - Ringer Bicarbonate, Elderly Abdominal Surgery
Phase 4UnknownChinese PLA General Hospital50002020-10-012020-10-22
Safety of RIV4 Versus IIV4 in Pregnant Women
Quadrivalent Recombinant Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccine - Safety, Adverse Event Following Immunisation
Phase 4CompletedDuke University3842019-09-052023-01-11
Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML
Gemtuzumab Ozogamicin - ECG, Pharmacokinetics
Phase 4CompletedPfizer512019-07-032022-03-25
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
RDD, VDD - Hematologic Neoplasms, Multiple Myeloma
Phase 4UnknownShandong Provincial Hospital1202019-03-302019-11-29
Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety.
Propofol sedation, Midazolam and Fentanyl sedation - Flexible Bronchoscopy, Sedation
Phase 4UnknownCopenhagen University Hospital at Herlev1282014-11-012015-06-30
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.
13-valent pneumococcal conjugate vaccine - 13-valent Pneumococcal Vaccine, Premature Birth
Phase 4CompletedPfizer2002010-10-012017-05-11
FDA Phase IV - Commitment - Retinal Function Study
Sildenafil, Placebo, Vardenafil (Levitra, BAY38-9456) - Safety
Phase 4CompletedBayer632005-02-012015-03-19

Narrower conditions

Influenza, Human (2)  ·  Alzheimer Disease (1)  ·  Hematologic Neoplasms (1)  ·  Hepatitis B (1)  ·  Hepatitis B, Chronic (1)  ·  Multiple Myeloma (1)  ·  Personal Satisfaction (1)  ·  Premature Birth (1)

Broader conditions

Infections (3)  ·  Virus Diseases (3)  ·  Orthomyxoviridae Infections (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Behavior (1)  ·  Blood Protein Disorders (1)  ·  Blood-Borne Infections (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chronic Disease (1)  ·  Communicable Diseases (1)  ·  DNA Virus Infections (1)

Interventions

Influenza Vaccines (3)  ·  CVnCoV COVID-19 vaccine (1)  ·  Fentanyl (1)  ·  FluLaval (1)  ·  GV-971 (1)  ·  Gemtuzumab (1)  ·  Memantine (1)  ·  Midazolam (1)  ·  Morphine (1)  ·  Nalbuphine (1)  ·  Ringer's Lactate (1)  ·  Sildenafil Citrate (1)  ·  Tablets (1)  ·  Vaccines (1)  ·  Vardenafil Dihydrochloride (1)

Sponsors

Duke University (2)  ·  First Affiliated Hospital Xi'an Jiaotong University (2)  ·  Pfizer (2)  ·  Bayer (1)  ·  Catholic Kwandong University (1)  ·  Centers for Disease Control and Prevention, China (1)  ·  Chinese PLA General Hospital (1)  ·  Copenhagen University Hospital at Herlev (1)  ·  Shandong Provincial Hospital (1)  ·  Sichuan Provincial People's Hospital (1)  ·  The First Affiliated Hospital of Zhengzhou University (1)  ·  Zhongda Hospital (1)

Countries

China (4)  ·  United States (3)  ·  Poland (2)  ·  Spain (2)  ·  Canada (1)  ·  Denmark (1)  ·  Hungary (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Elizabeth Barnett, MD (1)  ·  Elizabeth Schlaudecker, MD, MPH (1)  ·  Gao-Jun Teng, MD (1)  ·  Geeta K Swamy, MD (1)  ·  Geeta Swamy, MD (1)  ·  Karen R Broder, MD (1)  ·  Matthew Crist, MD (1)  ·  Matthew Zuber, MD (1)  ·  Min Joo Choi, Doctor (1)  ·  Paul F Clementsen, Professor (1)  ·  Qiang Wang (1)  ·  Qing-Lei Zeng (1)  ·  Satoshi Kamidani, MD, PhD (1)

Results publications

PMID 25780077, PMID 27902652, PMID 36273202, PMID 36892676, PMID 38140184, PMID 39229259, PMID 39382852

NIH funding

2009 (1), 2018 (1)